Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation

Retina

Volumn 32, Issue 6, 2012, Pages 1181-1189

  Rouvas, Alexandros A ^a   Chatziralli, Irini P ^a   Theodossiadis, Panagiotis G ^a   Moschos, Marilita M ^a   Kotsolis, Athanasios I ^a   Ladas, Ioannis D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

photodynamic therapy; ranibizumab; retinal angiomatous proliferation; treatment; triamcinolone

Indexed keywords

RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; HUMAN TISSUE; MALE; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA NEOVASCULARIZATION; RETINAL ANGIOMATOUS PROLIFERATION; RETREATMENT; STATISTICAL SIGNIFICANCE; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; PHOTOCHEMOTHERAPY; RETINAL NEOVASCULARIZATION; TRIAMCINOLONE; VISUAL ACUITY;

EID: 84861810158     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318235d8ce     Document Type: Article

References (44)

1. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416-434.
2. Cohen SY, Creuzot-Garcher C, Darmon J, et al. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol 2007;91: 1173-1176.
3. Maruko I, Iida T, Saito M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007;144:15-22.
4. Bottoni F, Massacesi A, Cigada M, et al. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005;123:1644-1650.
5. Bressler NM. Retinal anastomosis to choroidal neovasculariza-tion: a bum rap for a difficult disease. Arch Ophthalmol 2005; 123:1741-1743.
6. Fernandes LH, Freund KB, Yannuzzi LA, et al. The nature of focal areas of hyperfluorescence or hot spots imaged with in-docyanine green angiography. Retina 2002;22:557-568.
7. Meyerle CB, Freund KB, Iturralde D, et al. Intravitreal beva-cizumab (Avastin) for retinal angiomatous proliferation. Retina 2007;27:451-457.
8. Rouvas AA, Papakostas TD, Vavvas D, et al. Intravitreal ra-nibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angioma-tous proliferation: a prospective study. Retina 2009;29: 536-544.
9. Rouvas AA, Papakostas TD, Ntouraki A, et al. Angiographic and OCT features of retinal angiomatous proliferation. Eye (Lond) 2010;24:1633-1642.
10. Axer-Siegel R, Bourla D, Priel E, et al. Angiographic and flow patterns of retinal choroidal anastomoses in age-related macu-lar degeneration with occult choroidal neovascularization. Ophthalmology 2002;109:1726-1736.
11. Massacesi AL, Sacchi L, Bergamini F, Bottoni F. The prevalence of retinal angiomatous proliferation in age-related mac-ular degeneration with occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2008;246:89-92.
12. Viola F, Massacesi A, Orzalesi N, et al. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 2009;29:732-739.
13. Boscia F, Furino C, Sborgia L, et al. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 2004;138:1077-1079.
14. Boscia F, Parodi MB, Furino C, et al. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2006;244:1224-1232.
15. Krebs I, Krepler K, Stolba U, et al. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone ace-tonide and PDT versus PDT alone. Graefes Arch Clin Exp Ophthalmol 2008;246:237-243.
16. Nakata M, Yuzawa M, Kawamura A, Shimada H. Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 2006;141:968-970.
17. Borrillo JL, Sivalingam A, Martidis A, Federman JL. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 2003;121:558-561.
18. Boscia F, Furino C, Prascina F, et al. Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angi-omatous proliferation. Eur J Ophthalmol 2005;15:513-516.
19. Kuroiwa S, Arai J, Gaun S, et al. Rapidly progressive scar formation after transpupillary thermotherapy in retinal angio-matous proliferation. Retina 2003;23:417-420.
20. Johnson TM, Glaser BM. Focal laser ablation of retinal angi-omatous proliferation. Retina 2006;26:765-772.
21. Krieglstein TR, Kampik A, Ulbig M. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation. Br J Ophthalmol 2006;90:1357-1360.
22. Roth DB, Scott IU, Gloth JM, et al. Micropulsed laser photo-coagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation. Retina 2007;27:1201-1204.
23. Freund KB, Klais CM, Eandi CM, et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006;124:487-492.
24. Krebs I, Binder S, Stolba U. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006;244:863-867.
25. Mantel I, Ambresin A, Zografos L. Retinal angiomatous proliferation treated with a combination of intravitreal triamcino-lone acetonide and photodynamic therapy with verteporfin. Eur J Ophthalmol 2006;16:705-710.
26. Bottoni F, Romano M, Massacesi A, Bergamini F. Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photody-namic therapy. Graefes Arch Clin Exp Ophthalmol 2006;244: 1528-1533.
27. van de Moere A, Kak R, Sandhu SS, Talks SJ. Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 2007;143:701-704.
28. Abi-Ayad N, Mauget-Faysse M, Amara-Allieu S, Ardisson P. Systemic bevacizumab for retinal angiomatous proliferation associated with retinal pigment epithelial detachment. Eur J Ophthalmol 2007;17:987-991.
29. Costagliola C, Romano MR, dell'Omo R, et al. Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 2007;144:449-451.
30. Joeres S, Heussen FM, Treziak T, et al. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007;245:1597-1602.
31. Kang JH, Park KA, Chung SE, Kang SW. Retinal angiomatous proliferation and intravitreal bevacizumab injection. Korean J Ophthalmol 2007;21:213-215.
32. Lai TY, Chan WM, Liu DT, Lam DS. Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007;245: 1877-1880.
33. Ghazi NG, Knape RM, Kirk TQ, et al. Intravitreal bevacizu-mab (avastin) treatment of retinal angiomatous proliferation. Retina 2008;28:689-695.
34. Smith BT, Dhalla MS, Shah GK, et al. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Retina 2008;28:675-681.
35. Saito M, Shiragami C, Shiraga F, et al. Combined intravitreal bevacizumab and photodynamic therapy for retinal angioma-tous proliferation. Am J Ophthalmol 2008;146:935-941.
36. Treatment of Age-Related Macular Degeneration With Photo-dynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related mac-ular degeneration with verteporfin: one-year results of 2 randomized clinical trials\TAP report. Arch Ophthalmol 1999; 117:1329-1345.
37. Hemeida TS, Keane PA, Dustin L, et al. Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation. Br J Ophthalmol 2010;94: 701-705.
38. Gharbiya M, Allievi F, Recupero V, et al. Intravitreal bevaci-zumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina 2009;29:740-749.
39. Konstantinidis L, Mameletzi E, Mantel I, et al. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol 2009; 247:1165-1171.
40. Montero JA, Fernandez MI, Gomez-Ulla F, Ruiz-Moreno JM. Efficacy of intravitreal bevacizumab to treat retinal angioma-tous proliferation stage II and III. Eur J Ophthalmol 2009;19: 448-451.
41. Lee MY, Kim KS, Lee WK. Combination therapy of rani-bizumab and photodynamic therapy for retinal angiomatous proliferation with serous pigment epithelial detachment in Korean patients: twelve-month results. Retina 2011;31:65-73.
42. McBain VA, Kumari R, Townend J, Lois N. Geographic atrophy in retinal angiomatous proliferation. Retina 2011;31:1043-1052.
43. Rouvas AA, Papakostas TD, Ladas ID, Vergados I. Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2008;246:315-318.
44. Bearelly S, Espinosa-Heidmann DG, Cousins SW. The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation. Br J Ophthalmol 2008;92:191-196.